Wheeler new chief at Momenta

Cambridge-based Momenta Pharmaceuticals Inc., hired Craig A. Wheeler, a long-time industry executive and current board member, to be its next chief executive officer.

Wheeler will take over the executive suite from current chief Alan Crane on September 12; Crane will remain on Momenta's board. Wheeler most recently oversaw the operations of Chiron BioPharmaceuticals, as president of the $600 million, 2,300 person company based in Emoryville, Calif. Before that, he was a partner in Boston Consulting Group's health care consulting practice and as an engineer at drug firm Merck.

He holds undergraduate degrees in chemical engineering from Cornell University and an MBA from Wharton School at the University of Pennsylvania.
(By Keith Reed, Globe staff)